Vincenzo Summa

Via D. Montesano 49
Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

F2F-202, a Selective Histone Deacetylase 6 (HDAC6) Inhibitor, Behaves as an Arrow with Multiple Tips against Azole-Resistant C. albicans: Modulation of Yeast-to-Hyphae Transition, Trailing Effect, and Oxidative Stress.

F2F-202, a Selective Histone Deacetylase 6 (HDAC6) Inhibitor, Behaves as an Arrow with Multiple Tips against Azole-Resistant C. albicans: Modulation of Yeast-to-Hyphae Transition, Trailing Effect, and Oxidative Stress.

Journal: ACS infectious diseases

Published: May 22, 2026

Efficient and scalable photochemical coupling of pinacol and aza-pinacol in continuous-flow.

Efficient and scalable photochemical coupling of pinacol and aza-pinacol in continuous-flow.

Journal: Communications chemistry

Published: April 22, 2026

Amorfrutin-A, a membrane-targeting phytochemical active against multidrug-resistant Staphylococcus aureus: In vitro and in vivo activity and mechanism of action.

Amorfrutin-A, a membrane-targeting phytochemical active against multidrug-resistant Staphylococcus aureus: In vitro and in vivo activity and mechanism of action.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: February 03, 2026

Fine-tuning the combination of novel spirocyclic capping moieties and heterocyclic zinc binding groups for selective HDAC6 inhibition: design, synthesis, kinetic and biological studies.

Fine-tuning the combination of novel spirocyclic capping moieties and heterocyclic zinc binding groups for selective HDAC6 inhibition: design, synthesis, kinetic and biological studies.

Journal: European journal of medicinal chemistry

Published: December 23, 2025

Selective HDAC6 inhibition by Mesinostat impairs tumor growth and stemness in triple-negative breast cancer.

Selective HDAC6 inhibition by Mesinostat impairs tumor growth and stemness in triple-negative breast cancer.

Journal: Pharmacological research

Published: November 05, 2025

The role of dopaminergic signalling from physiology to neuroprotection in acute and chronic disorders.

The role of dopaminergic signalling from physiology to neuroprotection in acute and chronic disorders.

Journal: Neurobiology of disease

Published: September 29, 2025

Sustainable Joullié-Ugi and Continuous Flow Implementation Led to Novel Captopril-Inspired Broad-Spectrum Metallo-β-Lactamase Inhibitors.

Sustainable Joullié-Ugi and Continuous Flow Implementation Led to Novel Captopril-Inspired Broad-Spectrum Metallo-β-Lactamase Inhibitors.

Journal: Journal of medicinal chemistry

Published: August 15, 2025

A rapid and robust luciferase-based reporter system to assess SARS-CoV-2 protease activity.

A rapid and robust luciferase-based reporter system to assess SARS-CoV-2 protease activity.

Journal: Virology

Published: May 14, 2025

Challenging triple negative breast cancer through HDAC6 selective inhibition: Novel cap-group identification, structure-activity relationships, computational and biological studies.

Challenging triple negative breast cancer through HDAC6 selective inhibition: Novel cap-group identification, structure-activity relationships, computational and biological studies.

Journal: European journal of medicinal chemistry

Published: February 13, 2025

Integrating Surface Plasmon Resonance and Docking Analysis for Mechanistic Insights of Tryptase Inhibitors.

Integrating Surface Plasmon Resonance and Docking Analysis for Mechanistic Insights of Tryptase Inhibitors.

Journal: Molecules (Basel, Switzerland)

Published: February 12, 2025

Fixed combination of palmitoylethanolamide and melatonin in preventive therapy of migraine: results from a randomized clinical trial.

Fixed combination of palmitoylethanolamide and melatonin in preventive therapy of migraine: results from a randomized clinical trial.

Journal: Frontiers in nutrition

Published: February 06, 2025

Methyl-Transferase-Like Protein 16 (METTL16): The Intriguing Journey of a Key Epitranscriptomic Player Becoming an Emerging Biological Target.

Methyl-Transferase-Like Protein 16 (METTL16): The Intriguing Journey of a Key Epitranscriptomic Player Becoming an Emerging Biological Target.

Journal: Journal of medicinal chemistry

Published: August 16, 2024

Showing 1-12 of 78

Last Updated: 09/26/2026